Pure Global

HbA1c Direct - India CDSCO Medical Device Registration

HbA1c Direct is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000060_822d403e6cd840a0125b8b115e209a1e_32cca0ef7613c1ffd53c714a29d0a1c9. This device is marketed under the brand name a. The license holder is POCT Services Private Limited, and it is classified as Device Class Class B. The approving authority is North Delhi Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c Direct
UID: MFG/IVD/2021/000060_822d403e6cd840a0125b8b115e209a1e_32cca0ef7613c1ffd53c714a29d0a1c9

Brand Name

a

Device Class

Class B

Approving Authority

North Delhi Division

Product Information

Q-Lineยฎ HbA1c Direct kit is intended for in-vitro quantitative determination of PLATINUM% HbA1c (a) in human whole blood. Percent HbA1c measurements are used for monitoring long term glycemic control in diabetic patients

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing